Background. Cross-sectionalstudiesshowthatadiponectinishigherinolderthaninyoungeradultsbutlong-term changeinadiponectin,itsdeterminants,anditsrelationshiptofunctionaldeclineorsurvivalintheelderlypopulation havenotbeenevaluated.
T
HEadipocyte-derivedpeptideadiponectinhasemerged as a potentially crucial molecule to cardiometabolic disorders (1) .Inthelaboratory,adiponectinexhibitsinsulinsensitizing,anti-inflammatory,andantiatherogenicproperties (1) . Yet, although its metabolic benefits have been confirmedinclinicalstudies,therelationshipofcirculating adiponectintocardiovasculardisease(CVD)inhumanshas beeninconsistent (2) .Althoughaprotectiveassociationhas beendocumentedinyoungeradultswithoutprevalentCVD (3),thishasnotbeenreproducedingroupswithmanifest heartdisease(4,5)orinolderadults(2),wheretherelationshiphasinfactbeendirectionallyopposite.Thisparadoxical adverse association with CVD and mortality in older adultshasbeenreplicatedindifferentsettings (6) (7) (8) ,butits basisremainsunclear.
Itiswellrecognizedfromcross-sectionalstudiesthatcirculating adiponectin is higher in older than in younger adults (9, 10) .Togetherwiththeobservationthatmenwith exceptional longevity harbor genetic variants associated withgreateradiponectinlevels (11) ,thishasledtothepropositionthatthehigherconcentrationwithagecouldreflecta survivor bias (9, 11) . Contrariwise, the higher age-related ChangeinCirculatingAdiponectininAdvancedOldAge: DeterminantsandImpactonPhysicalFunctionand Mortality.TheCardiovascularHealthStudyAllStarsStudy levelsandlinktoincreasedmortalitysuggestthatresistance to adiponectin's beneficial actions (12) or, alternatively, a responsetoadverseprocesses(13)ordirectdeleteriouseffectscouldbeinvolved.Serialmeasurementofadiponectin inolderadultswouldshedlightonthebasisforhigherlevelsdocumentedcross-sectionally. Animportantaspectofagingisadeclineincognitiveand physicalfaculties,whichservesasaharbingerofmortality (14) .Obesity,dysglycemia,andCVDhavedistinctassociationswithcirculatingadiponectinlevels,andallarestrong determinantsoffunctionaldecline (15) .Definingtherelationshipofadiponectintofunctionalimpairmentinoldage couldhelptoclarifyitsreportedassociationwithmortality.
To address these questions, we measured levels of adiponectin9yearsapartinacohortsurvivingtoadvancedold agewhounderwentdetailedassessmentoffunctionalstatus. Ourobjectivesweretoidentifydeterminantsofadiponectin changeandtoexaminetheassociationofadiponectinand itsantecedentchangewithphysicalimpairmentandmortality inthisoldercohort.
Methods

Study Population and Procedures
TheAll Stars Study is an ancillary investigation of the Cardiovascular HealthStudy(CHS)whose objectiveisto assess determinants of successful aging. Details of both CHS and CHS All Stars have been previously reported (15, 16 (17, 18) .
Definitions of Risk Factors
Hypertensionwasdefinedbybloodpressuregreaterthanor equal to 140 mmHg systolic or greater than or equal to 90 mmHg diastolic or by self-report and antihypertensive treatment.Diabeteswasdefinedasafastingbloodglucosegreater thanorequalto126mg/dLorhypoglycemictherapy.Functional impairment was defined as the presence of physical disability(reporteddifficultywith≥1activitiesofdailyliving [ADLs] ) and/or cognitive impairment (a score <80 on the ModifiedMini-MentalStatusExamination),asdescribedpreviously (15 (16, 20) .
Outcomes
The functional outcome of incident physical disability was based on two measures,ADL difficulty and mobility impairment, ascertained at semiannual telephone contacts afterthe2005-2006examination.Thefirstmeasurewasdefinedasself-reporteddifficultyinoneofsixADLs(walking aroundthehouse,transferring,bathing,toileting,dressing, andeating).Forthesecondmeasure,mobilityimpairment, participantswereaskedaboutdifficultywithtwoactivities: walkinghalfamileandwalkingup10stairsteps.Follow-up questions determined the extent of difficulty (some, a lot, andunabletodo)or,forthosereportingnodifficulty,the degreeofease(veryeasy,somewhateasy,andnotthateasy) with these activities. The response for each activity was thenscoredonascalefrom−2to3from"veryeasytodo" to"unabletodo."Thetwoscoreswereaveragedtogenerate a mobility score with 11 values in half-point increments, withincreasingvaluesindicatinggreaterdifficulty.
All-causemortalityfollowingtheAll-Starsvisitwasascertainedbytelephonefollow-up,proxycontact,andreview ofobituaries.Follow-upforincidentphysicaldisabilityand all-causemortalitywasavailablethroughJune2009.
Measurement of Adiponectin
AdipokinetestingwasperformedattheCHSCoreLaboratoryin2008onserumstoredat−70°Csincevenipuncture in1996-1997and2005-2006.Adiponectinwasmeasured using an ELISA (R&D Systems, Minneapolis, MN) with pairedsamplesfrombothtimepointsruntogether.Theminimum detectable adiponectin concentration was 0.246 ng/ mL;intra-assayandinterassaycoefficientsofvariationwere 2.5%-4.7%and5.8%-6.9%,respectively.
Statistical Analysis
Adiponectin and its interval change were mildly positively skewed and varied by sex. We therefore examined levelsofcovariatesaccordingtosex-specifictertilesofadiponectinandtesteddifferencesusingchi-squareoranalysis of variance tests for trend. Continuous measures of adiponectinlevelandchangewereusedinallotheranalyses. Pearson correlation coefficients between adiponectin and body size, glucose, and C-reactive protein (CRP) were computedformenandwomenseparatelyin1996-1997and 2005-2006.Potentialdeterminantsofchangeinadiponectinincludedtheseandotherclinicalvariablesandtheirintervalchange,assessedinmultiplelinearregressionmodels. Positivelyskewedvariableswerelogtransformed. Associations of outcomes with adiponectin level or its changewereassessedwithmultivariableCoxmodels(incident ADLdifficultyandmortality)andgeneralizedestimatingequations(mobilityscore).Modelingwasdoneinthreestages,initiallyadjustingforage,sex,andrace;addingsignificantclinical covariates thereafter; and subsequently adjusting for interval weightchange.Allmodelsweretestedforeffectmodification bysex,race,CVD,andhealthstatus.Linearitywasassessedby plotting Lowess smoothers.Where departures from linearity wereobserved,linearsplineswereused.AllanalyseswereperformedwithSTATA,version11.0(CollegeStation,TX).
Results
CHS All-Stars participants with available adiponectin measurements(n=988)weremorelikelytobemale,younger, have better functional status, and report good-to-excellent healthcomparedwithAll-Starsparticipants(n=689)who didnothaveadiponectinmeasured.
There was a significant association between use of angiotensin-receptorblockersin1996-1997(ineightwomen and one man) and interval decline in adiponectin from 1996-1997 to [2005] [2006] 
Discussion
Toourknowledge,thisisthefirstreporttodatetoassess long-termlongitudinalchangeinadiponectininacommunitybased cohort and to examine the relationship of both adiponectin and its interval change with incident physical decline and all-cause mortality in an elderly population. Our study demonstrates that adiponectin does in fact increasewithage,aphenomenonthatwasmorepronounced inmenthaninwomen.Thisintervalincreaseinadiponectin wasbluntedinblackwomenbutwasassociated,independentofrace,withdecreasingweightorfastingglucose,useof specificmedications,and,inmen,loweralbumin.Thisinvestigation also showed circulating adiponectin to predict a higherincidenceofADLdifficulty,alongwithmorerapid onsetofmobilityimpairment.Yet,althoughintervalincrease inadiponectinwasalsoassociatedwithgreaterdeteriorationinthesephysicaldisabilitymeasures,therelationship waslargelyattributabletoanaccompanyingdeclineinweight. Inaddition,thecurrentstudyhighlightsapositiveassociation between adiponectin and its interval change with future mortality independent of measured covariates, including interval change in weight, although the association for a single measurement of adiponectin was only observed in whitesandonlyforlevelsgreaterthanorequalto20mg/L. Theobservationthatadiponectinconcentrationisgreater in older adults than their younger counterparts, as documentedpreviouslyinseveralcross-sectionalstudies(9,10), hasbeenproposedtorepresentasurvivaladvantageinthe contextofadiponectin'sfavorablecardiometabolicassociations (9, 11) . Indeed, genetic polymorphisms linked to highercirculatingadiponectinhavebeenfoundtobemore commonincentenariansthaninothercohorts(11).Yetseveral epidemiological studies in older adults have reported positive, not negative, associations between higher adiponectinandincidentCVDorall-causemortality(2,6-8). Thisfindingiscontrarytoexpectationbasedonresultsfrom laboratorystudiesandyoungercohorts,wheretheadipokine exhibitsaprotectivecardiometabolicprofile(1,3).Theresultingconundrumdoesnotappearexplainablebyweight lossandsarcopeniaorbyheartfailureorrenalinsufficiency, adverseconditionsthatraiseadiponectinlevels (2, 7, 8) .This hasledtotheconceptofadiponectinresistanceasanexplanationforboththehigheradiponectinlevelwithageandits adverseassociationwithoutcome (12) . Ourfindingsbasedonserialmeasurementofadiponectin yield insights into this question. The correlation between adiponectinandfastingglucosedidweakenatfollow-upin women,butnotinmen,suggestingpossibledevelopmentof adiponectin resistance in female participants. The inverse relationshipbetweenchangeinadiponectinandchangein fastingglucoseinbothsexesisinconsistent,however,with majorresistancetoadiponectin'smetaboliceffects,wherein adiponectinandglucosewouldriseintandem.
Moregenerally,ourresultsarecompatiblewiththepremisethattheage-relatedincreaseinadiponectinanditspositive association with subsequent physical disability and all-causemortalityreflectheightenedadiponectinsecretion in response to adverse processes that accompany aging. Lately, the notion that adiponectin may serve a general "housekeeping" function by facilitating phagocytosis of apoptotic cells by macrophages has gained currency (21) . Sucharoleforadiponectinthatgoesbeyonddirectinsulinsensitizing and antiatherogenic high-affinity signaling through the "AdipoR1" and "AdipoR2" receptors is supportedby:adiponectin's1,000-foldhigherplasmaconcentrationrelativetootheradipokines;discoveryofbindingof adiponectintothecalreticulinreceptoronthemacrophage surface (22) ;andrecognitionbyadiponectinof"apoptotic cell-associated molecular patterns" on dead cell surfaces (21) .Thus,throughlow-affinityinteractionswithdeadcells andmacrophages,thehighlyabundantpeptidecanpromote opsonization,therebyservingananti-inflammatoryfunction (21) .SucharoleforadiponectinwouldexplaintheassociationwithincreasedmortalityobservedhereorinotherstudiesofolderadultsandcohortswithprevalentCVD,inwhom higher circulating adiponectin would act as a marker for greaterhomeostaticdysregulationandassociatedapoptosis. Thesameconceptwouldalsoapplytoourphysicaldisability findings. Moreover, although adipose tissue is the principalsourceofcirculatingadiponectin,skeletalmuscle alsohasthecapacitytosecretethisadipokine (23) .Interestingly,recentdatashowthatadiponectinexpressionincreases inrhabdomyocytesofheartfailurepatients,withconcurrent downregulationofAdipoR1andthereceptor'sdownstream pathways,indicativeofadiponectinresistance (23) .These findingsraisethepossibilitythataging-associatedsarcopenia might exhibit the same pattern of adiponectin expressionandlocalresistanceobservedinheartfailure-associated skeletalmusclewasting.Tothedegreethatsuchheightened rhabdomyocyteexpressionmayaffectcirculatingadiponectin levels, the latter could reflect the severity of skeletal musclehomeostaticderangements.
Whatever the basis for the aging-related increase in adiponectin,thispeptidecouldalsohavedirectharmful effects-whetherthroughAdipoR1/R2,T-cadherin(24),or complementactivation(25)-withvariationacrosstissues depending on the degree of tissue-specific resistance. Indeed,murineoverexpressionofadiponectinleadstodiminishedbonemineraldensity(26),andhigheradiponectinhas been linked to osteopenia at non-load-bearing sites independentofbodymassindexinwomen (27) .
Given the association of adiponectin-raising polymorphismswithexceptionallongevity(11),however,itislikely thatthebeneficialglycometabolicassociationsofadiponectintrumpanysuchadverseeffects,althoughitispossible thatsuchadverseeffectscouldbeofgreaterconsequencein susceptibleolderadults.Thefindingthatthechangeinadiponectinlevelwasassociatedwithmortality(independent ofitsfinallevel)suggeststhat,incontrasttoagenetically determined higher lifelong adiponectin concentration, longitudinalincreaseinadiponectinwithaginghasnetnegativeimplicationsforsurvival. Wecouldnotdemonstrateasimilarrelationofadiponectin withmortalityforblacksasforwhites.AfricanAmerican participantsinour samplehadmorecomorbiditiesthan whites,andblackwomenhadasignificantlylowerinterval increase in adiponectin than white women.Although our findingofloweradiponectinlevelsforblackthanforwhite elderlyindividualsisconsistentwithapreviousreport(8), availabledatadonotsupportthenotionthattheadverseassociationsseenforadiponectinwithCVD(2)andmortality (8)areattenuatedinolderAfricanAmericans.Furthermore, we found no evidence of an adiponectin interaction with raceinrelationtophysicaldisabilityoutcomesorforintervalchangeinadiponectinandmortality.Totheextentthat effect-measure modification by race was present in our cohort, it likely underscores the complex multifaceted relationsofadiponectinwithglycometabolicandvascular factors and how the balance between its beneficial and harmfulassociationsvariesindifferentclinicalcontextsand populations.Whetherthedifferencesobservedherereflect race-specificgeneticvariationwarrantsadditionalstudy.
Several limitations must be acknowledged. Participants with available adiponectin measurements reported better healthstatusthantheremainingAll-Starscohort,suchthat these results apply togenerally healthier elders.Although thereisasurvivalbiasinthiscohortlivingtoadvancedold age,assessmentofincidentphysicaldisabilityandmortality after the last adiponectin measurement yields results that areinternallyvalid.Eveniftheindividualsstudiedherein wereavailablebyvirtueofasurvivaladvantagefromhigher lifelonglevelsofadiponectin,thisdoesnotnegatethefindingthatasurgeinadiponectininlatelifehasnegativeimplicationsforfurthersurvival.Anotherlimitationisthecurrent lack of information on cause of death; analyses of causespecificmortalitywillrequirelongerfollow-up.Moreover, fastinginsulinwasnotavailable,buttheobservedassociationsofadiponectinwithoutcomewerealsoindependentof fastingglucoseasameasureofprediabetes.Last,wedidnot undertakemeasurementofhigh-molecularweightadiponectin,afractionthathasbeenreportedtohavestrongerglycometabolicassociations(28)andwarrantscloserscrutiny.
Inconclusion,thepresentstudyofadultssurvivingtoadvancedoldageshowsthatadiponectinincreaseslongitudinallywithage,thatboththemagnitudeofthisincreaseand theresultingconcentrationindependentlypredictall-cause mortality,andthatthefinallevelofadiponectinisalsoindependentlyrelatedtophysicaldeclineinthispopulation.The mechanismsunderlyingadiponectin'sage-relatedincrease anditsadverseassociationwithphysicalfunctionandmortalityrequirefurtherstudy.
